The Food and Drug Administration (FDA) has granted Fast Track designation to AV-1959R for the prevention of Alzheimer disease in cognitively unimpaired individuals with biomarker evidence of amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results